DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 03/04/2026 declared a dividend of $2.5200 per share

Amgen Inc (NASDAQ:AMGN) on 03/04/2026 declared a dividend of $ 2.5200 per share payable on June 05, 2026 to shareholders of record as of May 15, 2026.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 2.6737401485% and has increased its dividends for 14 successive years.

Amgen Inc's market cap is $ 203,228,636,000 and has a PE ratio of 26.49. The stock price closed yesterday at $ 377.00 and has a 52 week low/high of $ 261.43 and $ 391.29.

Amgen Inc. is a biotechnology company dedicated to discovering, developing, manufacturing, and delivering human therapeutics. It focuses on addressing high unmet medical needs to enhance health outcomes and improve lives. Operating primarily in the human therapeutics segment, Amgen's extensive portfolio includes well-known products such as Aranesp, ENBREL, Prolia, Neulasta, Otezla, and Repatha, among others. These therapies target various conditions, showcasing Amgen's commitment to leveraging its expertise in biotechnology to provide innovative solutions for patients.

For more information on Amgen Inc click here.